Your Questions, Answered
We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.
You can view a snapshot of the Home screen on your iOS device if you add the Eversense® App widget to your widget page. For information on managing widgets, consult your iOS device user guide.
You can view a snapshot of the Home screen on your Android device if you swipe down on your device to show the notification tray. The app must be running in the background. This will show you the latest glucose.
To log out of your Eversense® account, tap About > My Account > Log Out.
IMPORTANT: If you log out, no glucose data will be displayed on the app until you log back in using the email and password you used to create your account.
For security purposes if you enter an incorrect password three consecutive times in the mobile app, your account will be locked for 30 minutes. During this time, you will not have access to your CGM data on the mobile app.
The Eversense Mobile App will periodically check to confirm your log in information has not been changed via your Eversense DMS account.
If you change your Eversense account password from your DMS log in screen or the DMS Change Password page, you must log out of the Eversense Mobile App and log back in using the new password. If the passwords do not match, the Eversense Mobile App will notify you and indicate that some features are not available, including not being able to sync your data to your DMS account, not being able to add Eversense NOW users to your Circle, and not being able to make changes to your profile picture.
The Weekly Modal Summary report shows your last seven days of glucose readings summarized in a
24-hour line graph format to help find patterns during the day.
- The blue line is the average of the last seven days of your readings in an hour time block.
- The red bars show the highest and lowest actual readings in the same hour time block.
- The red horizontal dotted lines are your pre-set High and Low Glucose Alert levels.
- The green horizontal dotted lines are your pre-set High and Low Glucose Target levels.
This report also provides summary statistics (average readings, standard deviation of readings), glucose target performance (percent within, above and below glucose target levels), and glucose reading highs and lows (percent of readings that fall within the low and high glucose target levels).
The information is shown based on mealtime slots.
The Glucose Pie Chart report shows in graphical format what percent of your readings within a given time period are within, below or above your Glucose Target levels. You can choose the last 1, 7, 14, 30 or 90 days.
Still have questions?
The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
PP-SENS-E3-GBL-0060